Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03321786
Other study ID # 827730
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 6, 2017
Est. completion date October 2024

Study information

Verified date June 2023
Source University of Pennsylvania
Contact Richard L Doty, PhD
Phone 215-662-6580
Email richard.doty@uphs.upenn.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to determine whether survivors of Legionnaires' disease suffer smell loss. A quantitative olfactory test will be performed by the participants. Such testing will require approximately 20-30 minutes of the participant's time. The participants will take the University of Pennsylvania Smell Identification Test (UPSIT), a scratch-and-sniff test to assess their ability to identify odors in a forced- choice format. Volunteers will also complete a questionnaire asking personal history, demographic questions, and medical history.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date October 2024
Est. primary completion date May 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Persons of generally good health, as obtained from a screening questionnaire who are 18 years of age and older - Both men and women of all ethnic backgrounds will be accepted. Exclusion Criteria: - Age less than 18 - Pregnant Women - Persons who mental competence is limited, such as those with dementia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
The University of Pennsylvania Smell Identification Test (UPSIT)
This standardized test, the most widely used olfactory test in the world, is derived from basic psychological test measurement theory and focuses on the comparative ability of subjects to identify odorants at the suprathreshold level. The UPSIT consists of four envelope-sized booklets, each containing ten "scratch and sniff" odorants embedded in 10- 50-µm polymer microcapsules positioned on brown strips at the bottom of the pages of the booklets.

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Score on the University of Pennsylvania Smell Identification Test The number of correct odor identification responses out of 40 from the standardized University of Pennsylvania Smell Identification Test.
The total number of correct responses will then be compared to standard norms of correct responses based on demographic information such as age and sex. Comparing the scores to the standard norms collected will indicate whether a volunteer is normosmic, hyposmic, or anosmic.
20-30 Minutes
Secondary Questionnaire Responses These are various demographic and medical history questions regarding exposure to Legionella Pneumonia and current experiences post diagnosis and treatment. 20-30 Minutes
See also
  Status Clinical Trial Phase
Completed NCT02884700 - Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011. N/A
Completed NCT01784770 - Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) N/A
Completed NCT04106037 - Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.